Zenas BioPharma, Inc. Income Tax Expense
Zenas BioPharma, Inc. (ZBIO) reported Income Tax Expense of $114.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-13
- Zenas BioPharma, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $114.00K, a 470.00% increase year-over-year.
- Zenas BioPharma, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $106.00K.
- Zenas BioPharma, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- Zenas BioPharma, Inc. income tax expense (benefit) for the quarter ending 2025-06-30 was $20.00K.
- Zenas BioPharma, Inc. income tax expense (benefit) for fiscal 2025 was -$79.00K, a 118.41% decline from fiscal 2024.
- Zenas BioPharma, Inc. income tax expense (benefit) for fiscal 2024 was $429.00K, a 42.52% increase from fiscal 2023.
- Zenas BioPharma, Inc. income tax expense (benefit) for fiscal 2023 was $301.00K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $114.00K 10-Q · filed 2026-08-13 | $114.00K 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $106.00K derived: sum of 2 quarters · filed 2026-03-16 | $126.00K derived: sum of 3 quarters · filed 2026-08-13 | -$79.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $20.00K derived: sum of 2 quarters · filed 2026-08-13 | -$185.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $20.00K 10-Q · filed 2026-08-13 | -$185.00K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$205.00K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $429.00K 10-K · filed 2026-03-16 | |||
| 2023-12-31 | $301.00K 10-K · filed 2025-03-11 |